Recent advances in equine wound management. Part 2: adjunctive therapies

Complications such as dehiscence and exuberant granulation tissue remain significant challenges in equine wound management. Thorough clinical assessment, including imaging when appropriate, is essential for identifying factors that impede healing. Biofilm is likely present in many chronic wounds, making repeated debridement and targeted topical therapy key components of treatment. Several topical agents and adjunctive modalities, including low-frequency ultrasound, extracorporeal shockwave therapy, platelet-rich plasma and amniotic membrane show potential benefits, though high-quality evidence in horses remains limited. This review underscores the importance of regular wound evaluation, early recognition of complicating factors and adherence to evidence-based management strategies while the role of emerging therapies continues to be refined through larger clinical studies.